These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 30554355

  • 1. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V, Caminiti SP, Riva N, Magnani G, Silani V, Perani D.
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.
    Tondo G, Mazzini L, Caminiti SP, Sarnelli MF, Corrado L, Matheoud R, D'Alfonso S, Cantello R, Sacchetti GM, Perani D, Comi C, De Marchi F.
    Neuroimage Clin; 2022 Mar; 36():103222. PubMed ID: 36223668
    [Abstract] [Full Text] [Related]

  • 3. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.
    Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chiò A.
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):844-52. PubMed ID: 24445987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype.
    Floeter MK, Bageac D, Danielian LE, Braun LE, Traynor BJ, Kwan JY.
    Neuroimage Clin; 2016 May; 12():1035-1043. PubMed ID: 27995069
    [Abstract] [Full Text] [Related]

  • 6. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers.
    Lee SE, Sias AC, Mandelli ML, Brown JA, Brown AB, Khazenzon AM, Vidovszky AA, Zanto TP, Karydas AM, Pribadi M, Dokuru D, Coppola G, Geschwind DH, Rademakers R, Gorno-Tempini ML, Rosen HJ, Miller BL, Seeley WW.
    Neuroimage Clin; 2017 May; 14():286-297. PubMed ID: 28337409
    [Abstract] [Full Text] [Related]

  • 7. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C, Karadima G, Koutsis G, Breza M, Papageorgiou SG, Paraskevas GP, Kapaki E, Panas M.
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [Abstract] [Full Text] [Related]

  • 8. The involvement of language-associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations.
    Tahedl M, Tan EL, Chipika RH, Lope J, Hengeveld JC, Doherty MA, McLaughlin RL, Hardiman O, Hutchinson S, McKenna MC, Bede P.
    Brain Behav; 2023 Nov; 13(11):e3250. PubMed ID: 37694825
    [Abstract] [Full Text] [Related]

  • 9. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H.
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [Abstract] [Full Text] [Related]

  • 10. The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.
    Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF.
    Neurocase; 2014 Nov; 20(1):110-20. PubMed ID: 23199140
    [Abstract] [Full Text] [Related]

  • 11. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
    De Vocht J, Blommaert J, Devrome M, Radwan A, Van Weehaeghe D, De Schaepdryver M, Ceccarini J, Rezaei A, Schramm G, van Aalst J, Chiò A, Pagani M, Stam D, Van Esch H, Lamaire N, Verhaegen M, Mertens N, Poesen K, van den Berg LH, van Es MA, Vandenberghe R, Vandenbulcke M, Van den Stock J, Koole M, Dupont P, Van Laere K, Van Damme P.
    JAMA Neurol; 2020 Aug 01; 77(8):1008-1017. PubMed ID: 32421156
    [Abstract] [Full Text] [Related]

  • 12. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ, Baker M, Rademakers R, Mackenzie IR.
    Brain; 2012 Mar 01; 135(Pt 3):709-22. PubMed ID: 22344582
    [Abstract] [Full Text] [Related]

  • 13. FDG-PET in presymptomatic C9orf72 mutation carriers.
    Popuri K, Beg MF, Lee H, Balachandar R, Wang L, Sossi V, Jacova C, Baker M, Shahinfard E, Rademakers R, Mackenzie IRA, Hsiung GR.
    Neuroimage Clin; 2021 Mar 01; 31():102687. PubMed ID: 34049163
    [Abstract] [Full Text] [Related]

  • 14. Brain FDG-PET changes in ALS and ALS-FTD.
    Renard D, Collombier L, Castelnovo G, Fourcade G, Kotzki PO, LaBauge P.
    Acta Neurol Belg; 2011 Dec 01; 111(4):306-9. PubMed ID: 22368970
    [Abstract] [Full Text] [Related]

  • 15. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K, Vanhee A, Verschueren J, De Coster L, Driesen A, Dupont P, Robberecht W, Van Damme P.
    JAMA Neurol; 2014 May 01; 71(5):553-61. PubMed ID: 24615479
    [Abstract] [Full Text] [Related]

  • 16. Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia.
    Cerami C, Dodich A, Lettieri G, Iannaccone S, Magnani G, Marcone A, Gianolli L, Cappa SF, Perani D.
    Cortex; 2016 Oct 01; 83():101-12. PubMed ID: 27498041
    [Abstract] [Full Text] [Related]

  • 17. The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.
    Giannoccaro MP, Bartoletti-Stella A, Piras S, Casalena A, Oppi F, Ambrosetto G, Montagna P, Liguori R, Parchi P, Capellari S.
    J Alzheimers Dis; 2018 Oct 01; 62(2):687-697. PubMed ID: 29480190
    [Abstract] [Full Text] [Related]

  • 18. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
    Van Mossevelde S, van der Zee J, Gijselinck I, Engelborghs S, Sieben A, Van Langenhove T, De Bleecker J, Baets J, Vandenbulcke M, Van Laere K, Ceyssens S, Van den Broeck M, Peeters K, Mattheijssens M, Cras P, Vandenberghe R, De Jonghe P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C, Belgian Neurology consortium.
    Brain; 2016 Feb 01; 139(Pt 2):452-67. PubMed ID: 26674655
    [Abstract] [Full Text] [Related]

  • 19. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An 18F-FDG PET/MRI Study.
    Zanovello M, Sorarù G, Campi C, Anglani M, Spimpolo A, Berti S, Bussè C, Mozzetta S, Cagnin A, Cecchin D.
    J Nucl Med; 2022 May 01; 63(5):777-784. PubMed ID: 34503963
    [Abstract] [Full Text] [Related]

  • 20. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.
    Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR, Parisi JE, Lucas JA, Petersen RC, Rademakers R.
    Brain; 2012 Mar 01; 135(Pt 3):765-83. PubMed ID: 22366793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.